HEALTHJun 1 · 09:00 UTCKFF HEALTH NEWSMaia Rosenfeld

Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight

Telehealth companies offering GLP-1 weight loss medications face scrutiny after patients report severe adverse effects and dosage errors. Karleigh McClain was hospitalized following an overdose linked to a semaglutide prescription from a telehealth provider, highlighting concerns about medication safety and inadequate oversight in online healthcare services.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Karleigh McClainpersonsemaglutidetopicGLP-1stopictelehealth companyorganizationEli LillyorganizationNovo NordiskorganizationKFForganizationFood and Drug Administrationorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 29 · 01:04 UTC
Weight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concerns
HEALTHMay 28 · 22:58 UTC
Alarming rise in weight loss drug overdoses
HEALTHApr 26 · 13:00 UTC
Patients taking weight-loss drugs often make 5 critical mistakes, doctor warns
HEALTHApr 22 · 18:18 UTC
HRT provider censured by UK regulator for ‘systemic failures’ that put patients at risk
HEALTHApr 14 · 21:19 UTC
FDA asks Lilly for more safety data on weight loss pill Foundayo
HEALTHMay 29 · 08:30 UTC
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’